- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Striated muscle.
Displaying page 1 of 1.
EudraCT Number: 2018-000391-15 | Sponsor Protocol Number: AIFA-2016-02364869 | Start Date*: 2018-06-05 | |||||||||||||||||||||
Sponsor Name:Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia | |||||||||||||||||||||||
Full Title: Multicentric, open-label, prospective study of subcutaneous tocilizumab in adult patients with refractory myositis | |||||||||||||||||||||||
Medical condition: Myositis (dermatomyositis [DM] or polymyositis [PM]) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000901-35 | Sponsor Protocol Number: 2016-02 | Start Date*: 2017-07-10 |
Sponsor Name:ASISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
Full Title: Riluzole for the treatment of spasticity in the traumatic chronic spinal cord injury condition: Adaptive, Multicenter, placebo-controlled, randomised, double blind trial in a Rare Disorder” RILUSCI | ||
Medical condition: the traumatic chronic spinal cord injury condition | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002932-15 | Sponsor Protocol Number: 2014-002932-15 | Start Date*: 2014-09-10 | |||||||||||
Sponsor Name:Bispebjerg University Hospital | |||||||||||||
Full Title: The effect of inhaled glucocorticoids on the content of Na+/K+ pumps in human skeletal muscle | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005762-34 | Sponsor Protocol Number: MGCDB001 | Start Date*: 2021-07-15 | |||||||||||
Sponsor Name:Medical University of Lublin | |||||||||||||
Full Title: A phase 2 clinical trial assessing the efficacy and safety of adding cladribine for treatment modifying course of seropositive myasthenia gravis | |||||||||||||
Medical condition: Myasthenia gravis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000383-15 | Sponsor Protocol Number: BAY80-6946/19176 | Start Date*: 2023-06-05 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Bayer AG | ||||||||||||||||||||||||||||||||||||||
Full Title: A non-randomized, open-label, multi-center, Phase I/II study of PI3K inhibitor copanlisib in pediatric patients with relapsed/refractory solid tumors or lymphoma | ||||||||||||||||||||||||||||||||||||||
Medical condition: Relapsed or refractory solid tumors or lymphoma in children Neuroblastoma Osteosarcoma Rhabdomyosarcoma Ewing sarcoma | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
